Standards for Plasma and Serum Proteomics in Early Cancer Detection: A Needs Assessment Report from the National Institute of Standards and Technology-National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18

Standards for Plasma and Serum Proteomics in Early Cancer Detection: A Needs Assessment Report from the National Institute of Standards and Technology-National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18–19, 2005

Published:2006-09-01 Issue:9 Volume:52 Page:1669-1674
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Barker Peter E¹,Wagner Paul D²,Stein Stephen E³,Bunk David M¹,Srivastava Sudhir²,Omenn Gilbert S⁴

Affiliation:

1. NIST-National Cancer Institute Cancer Biomarker Reference Laboratory,

2. Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD

3. NIST Mass Spectrometry Data Center, and Analytical Chemistry Division, NIST, Gaithersburg, MD

4. Center for Biomedical Proteomics and Center for Computational Medicine & Biology, University of Michigan, Ann Arbor, MI

Abstract

Abstract NIST and the National Cancer Institute cosponsored a workshop on August 18–19, 2005, to examine needs for reference materials for early cancer detection. This meeting focused on standards, methods, assays, reagents, and technologies. Needs for plasma and serum proteomics, DNA methylation, and specimen reference collections were discussed, and recommendations from participants were solicited. This report summarizes the discussion and recommendations for proteomics reference materials.

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/52/9/1669/32685657/clinchem1669.pdf

Reference32 articles.

1. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, et al. MGC Project Team. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res2004;14:2121-2127.

2. Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Investigating diversity in human plasma proteins. Proc Natl Acad Sci U S A2005;102:10852-10857.

3. Misek DE, Kuick R, Wang H, Galchev V, Deng B, Zhao R, et al. A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics2005;5:3343-3352.

4. Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ, et al. Proteomics: new perspectives, new biomedical opportunities. Lancet2000;356:1749-1756.

5. Tsur D, Tanner S, Zandi E, Bafna V, Pevzner PA. Identification of posttranslational modifications by blind search of mass spectra. Nat Biotechnol2005;23:1562-1567.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrated proteomic and glycoproteomic study for differences on glycosylation occupancy in rheumatoid arthritis;Analytical and Bioanalytical Chemistry;2019-02-07

2. Towards Translational Systems Biology of Inflammation;Translational Systems Biology;2015

3. Role of beta-defensin 2 and interleukin-4 receptor as stroke outcome biomarkers;Journal of Neurochemistry;2014-02-11

4. Role of Infrared Spectroscopy in Proteomics and Subsequently the Biomarker Analysis;Current Proteomics;2012-05-01

5. Impact of Preanalytic Factors on the Design and Application of Integral Biomarkers for Directing Patient Therapy;Clinical Cancer Research;2012-03-14